High C-reactive protein and amylase levels as prognostic markers in non-pancreatic severe sepsis patients

Trakya Universitesi Tip Fakultesi Dergisi

Volumn 26, Issue 1, 2009, Pages 9-17

  Hekimoǧlu Şahin, Sevtap ^a   Memiş, Dilek ^a   Süt, Necdet ^b  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Amylase; C reactive protein; Prognostic factor; Severe sepsis

Indexed keywords

AMYLASE; C REACTIVE PROTEIN;

AMYLASE BLOOD LEVEL; APACHE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEPSIS; SERUM; SURVIVAL;

EID: 70349127752     PISSN: 13013149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Tribl B, Sibbald WJ, Vogelsang H, Spitzauer S, Gangl A, Madl C. Exocrine pancreatic dysfunction in sepsis. Eur J Clin Invest 2003;33:239-243
2. Weaver DW, Busuito MJ, Bouwman DL, Wilson RF. Interpretation of serum amylase levels in the critically ill patient. Crit Care Med 1985;13:532-533
3. Tribl B, Sibbald WJ. Pancreatic dysfunction in critical illness. In: Vincent JL, editor. Yearbook of intensive care and emergency medicine. Berlin: Springer; 2001. p. 628-635
4. Tribl B, Madl C, Mazal PR, Schneider B, Spitzauer S, Vogelsang H, et al. Exocrine pancreatic function in critically ill patients: septic shock versus non-septic patients. Crit Care Med 2000;28:1393-1398 (Pubitemid 30324512)
5. Fish RE, Lang CH, Spitzer JA. Regional blood flow during continuous low-dose endotoxin infusion. Circ Shock 1986;18:267-275
6. Hiltebrand LB, Krejci V, Banic A, Erni D, Wheatley AM, Sigurdsson GH. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med 2000;28:3233-3241 (Pubitemid 30743710)
7. Booke M, Hinder F, McGuire R, Traber LD, Traber DL. Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: effects on regional blood flow. Shock 1996;5:362-370 (Pubitemid 126812845)
8. Vaccaro MI, Calvo EL, Suburo AM, Sordelli DO, Lanosa G, Iovanna JL. Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. Dig Dis Sci 2000;45:915-926 (Pubitemid 30238253)
9. Vaccaro MI, Dagrosa MA, Mora MI, Tiscornia OM, Sordelli DO. The effect of chronic intraperitoneal infusion of bacterial endotoxin on exocrine pancreas function in rats. Int J Pancreatol 1996;19:49-54.
10. Takahashi M, Maemura K, Sawada Y, Yoshioka T, Sugimoto T. Hyperamylasemia in critically injured patients. J Trauma 1980;20:951-955
11. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-778
12. Roumen RM, Redl H, Schlag G, Zilow G, Sandtner W, Koller W, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-480
13. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995;21 Suppl 2:S258-63.
14. Póvoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragão A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998;24:1052-1056
15. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995;108:1288-1291
16. Pinilla JC, Hayes P, Laverty W, Arnold C, Laxdal V. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 1998;124:799-805. (Pubitemid 28463280)
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829
19. Vitale GC, Larson GM, Davidson PR, Bouwman DL, Weaver DW. Analysis of hyperamylasemia in patients with severe head injury. J Surg Res 1987;43:226-233 (Pubitemid 17160464)
20. Rattner DW, Gu ZY, Vlahakes GJ, Warshaw AL. Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Surg 1989;209:279-283
21. Manjuck J, Zein J, Carpati C, Astiz M. Clinical significance of increased lipase levels on admission to the ICU. Chest 2005;127:246-250 (Pubitemid 41724584)
22. Weaver DW, Bouwman DL, Walt AJ, Clink D, Resto A, Stephany J. A correlation between clinical pancreatitis and isoenzyme patterns of amylase. Surgery 1982;92:576-580
23. Pace BW, Bank S, Wise L, Burson LC, Borrero E. Amylase isoenzymes in the acute abdomen: an adjunct in those patients with elevated total amylase. Am J Gastroenterol 1985;80:898-901. (Pubitemid 16233541)
24. Garrison R. Amylase. Emerg Med Clin North Am 1986;4:315-327
25. Fantini GA, Shiono S, Bal BS, Shires GT. Adrenergic mechanisms contribute to alterations in regional perfusion during normotensive E. coli bacteremia. J Trauma 1989;29:1252-1257 (Pubitemid 19251885)
26. Lang CH, Bagby GJ, Ferguson JL, Spitzer JJ. Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol 1984;246:R331-7.
27. Gullo L, Cavicchi L, Tomassetti P, Spagnolo C, Freyrie A, D'Addato M. Effects of ischemia on the human pancreas. Gastroenterology 1996;111:1033-1038
28. Warshaw AL, O'Hara PJ. Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1978;188:197-201.
29. Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997;156:825-832 (Pubitemid 27396422)
30. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Mélot C, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123:2043-2049 (Pubitemid 36706731)